Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

The Elusive Search for Success: Defining and Measuring Implementation Outcomes in a Real-World Hospital Trial.

Shepherd HL, Geerligs L, Butow P, Masya L, Shaw J, Price M, Dhillon HM, Hack TF, Girgis A, Luckett T, Lovell M, Kelly B, Beale P, Grimison P, Shaw T, Viney R, Rankin NM.

Front Public Health. 2019 Oct 18;7:293. doi: 10.3389/fpubh.2019.00293. eCollection 2019.

2.

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.

Whitford HS, Kalinowski P, Schembri A, Grimison P, Stockler M, Martin A, Toner GC, Davis ID, Maruff P, Olver IN; Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

Support Care Cancer. 2019 Oct 23. doi: 10.1007/s00520-019-05095-3. [Epub ahead of print]

PMID:
31642990
3.

Estimating survival time in older adults receiving chemotherapy for advanced cancer.

Moth EB, Blinman P, Stefanic N, Naganathan V, Grimison P, Stockler MR, Beale P, Martin A, Kiely BE.

J Geriatr Oncol. 2019 Sep 6. pii: S1879-4068(19)30216-4. doi: 10.1016/j.jgo.2019.08.013. [Epub ahead of print]

PMID:
31501013
4.

The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.

Mercieca-Bebber R, Costa DS, Norman R, Janda M, Smith DP, Grimison P, Gamper EM, King MT.

Med J Aust. 2019 Jun;210(11):499-506. doi: 10.5694/mja2.50207. Epub 2019 Jun 2.

PMID:
31155722
5.

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.

McCrary JM, Goldstein D, Sandler CX, Barry BK, Marthick M, Timmins HC, Li T, Horvath L, Grimison P, Park SB.

Support Care Cancer. 2019 Oct;27(10):3849-3857. doi: 10.1007/s00520-019-04680-w. Epub 2019 Feb 12.

PMID:
30756229
6.

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.

Mersiades AJ, Stockler MR, Olver IN, Grimison P.

Med J Aust. 2019 Jan;210(1):11-12.e1. doi: 10.5694/mja17.01099. Epub 2018 Dec 28. No abstract available.

PMID:
30636299
7.

Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.

Moth EB, Kiely BE, Stefanic N, Naganathan V, Martin A, Grimison P, Stockler MR, Beale P, Blinman P.

J Geriatr Oncol. 2019 Mar;10(2):210-215. doi: 10.1016/j.jgo.2018.11.004. Epub 2018 Nov 28.

PMID:
30503312
8.

Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial.

Butow P, Shaw J, Shepherd HL, Price M, Masya L, Kelly B, Rankin NM, Girgis A, Hack TF, Beale P, Viney R, Dhillon HM, Coll J, Kelly P, Lovell M, Grimison P, Shaw T, Luckett T, Cuddy J, White F; ADAPT Program Group.

BMC Cancer. 2018 Nov 7;18(1):1077. doi: 10.1186/s12885-018-4962-9.

9.

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.

Mersiades AJ, Stockler MR, Olver IN, Grimison P.

Med J Aust. 2018 Nov 12. [Epub ahead of print] No abstract available.

PMID:
30404590
10.

Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.

Moth EB, Kiely BE, Stefanic N, Naganathan V, Martin A, Grimison P, Stockler MR, Beale P, Blinman P.

J Geriatr Oncol. 2019 Mar;10(2):202-209. doi: 10.1016/j.jgo.2018.08.010. Epub 2018 Sep 14.

PMID:
30224184
11.

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, McGregor I, Olver I, Allsop DJ, Gedye C, Kirby AC, Morton RL, Fox P, Clarke S, Briscoe K, Aghmesheh M, Wong N, Walsh A, Hahn C, Grimison P.

BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.

12.

Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study.

Malalasekera A, Blinman PL, Dhillon HM, Stefanic NA, Grimison P, Jain A, D'Souza M, Kao SC, Vardy JL.

J Oncol Pract. 2018 Oct;14(10):e621-e630. doi: 10.1200/JOP.18.00125. Epub 2018 Sep 12.

PMID:
30207854
13.

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.

Lawrence NJ, Chan H, Toner G, Stockler MR, Martin A, Yip S, Wong N, Yeung A, Mazhar D, Pashankar F, Frazier L, McDermott R, Walker R, Tan H, Davis ID, Grimison P; ANZUP.

BMC Cancer. 2018 Aug 29;18(1):854. doi: 10.1186/s12885-018-4745-3.

14.

A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors.

Smith AB, Rutherford C, Butow P, Olver I, Luckett T, Grimison P, Toner G, Stockler M, King M.

Psychooncology. 2018 Apr;27(4):1129-1137. doi: 10.1002/pon.4596. Epub 2018 Jan 11.

PMID:
29171109
15.

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.

Herzog S, Shanahan M, Grimison P, Tran A, Wong N, Lintzeris N, Simes J, Stockler M, Morton RL.

Pharmacoeconomics. 2018 Jan;36(1):67-78. doi: 10.1007/s40273-017-0565-6.

PMID:
28866778
16.

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

Tandstad T, Kollmannsberger CK, Roth BJ, Jeldres C, Gillessen S, Fizazi K, Daneshmand S, Lowrance WT, Hanna NH, Albany C, Foster R, Cedermark GC, Feldman DR, Powles T, Lewis MA, Grimison PS, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl GJ, Nichols CR.

J Clin Oncol. 2017 Nov 1;35(31):3525-3528. doi: 10.1200/JCO.2017.73.4723. Epub 2017 Aug 30. No abstract available.

17.

Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.

McCrary JM, Goldstein D, Boyle F, Cox K, Grimison P, Kiernan MC, Krishnan AV, Lewis CR, Webber K, Baron-Hay S, Horvath L, Park SB; IN FOCUS Delphi working party.

Support Care Cancer. 2017 Nov;25(11):3485-3493. doi: 10.1007/s00520-017-3772-y. Epub 2017 Jun 7. Review.

PMID:
28589310
18.

e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer.

Heiniger LE, Smith AB, Olver I, Grimison P, Klein B, Wootten A, Abbott JM, Price MA, McJannett M, Tran B, Stockler MR, Gurney H, Butow PN.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12698. Epub 2017 May 22.

PMID:
28544085
19.

Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer.

Kandula T, Farrar MA, Kiernan MC, Krishnan AV, Goldstein D, Horvath L, Grimison P, Boyle F, Baron-Hay S, Park SB.

Clin Neurophysiol. 2017 Jul;128(7):1166-1175. doi: 10.1016/j.clinph.2017.04.009. Epub 2017 Apr 25. Review.

PMID:
28511129
20.

Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.

Lomax AJ, Beith J, Bhadri V, Boyer M, Grimison P, Horvath LG, Kao S, Tattersall M, Thomas D, McNeil C.

Intern Med J. 2016 Dec;46(12):1392-1398. doi: 10.1111/imj.13232.

PMID:
27554283
21.

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D, Gebski V, Friedlander M, Yeung A, Wong N, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong S, Lewis C, Vasey P, Grimison P.

Ann Oncol. 2016 Dec;27(12):2302-2303. doi: 10.1093/annonc/mdw313. Epub 2016 Aug 8. No abstract available.

PMID:
27502724
22.

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.

Ferraro D, Goldstein D, O'Connell RL, Zalcberg JR, Sjoquist KM, Tebbutt NC, Grimison P, McLachlan S, Lipton LL, Vasey P, Gebski VJ, Aiken C, Cronk M, Ng S, Karapetis CS, Shannon J; behalf of the the Australasian Gastro-Intestinal Trials Group.

Cancer Chemother Pharmacol. 2016 Aug;78(2):361-7. doi: 10.1007/s00280-016-3089-4. Epub 2016 Jun 22.

PMID:
27335026
23.

The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.

Roncolato FT, Chatfield M, Houghton B, Toner G, Stockler M, Thomson D, Friedlander M, Gurney H, Rosenthal M, Grimison P; Australian and New Zealand Urogenital Prostate Cancer Trials Group (ANZUP).

Intern Med J. 2016 Aug;46(8):893-8. doi: 10.1111/imj.13158. Erratum in: Intern Med J. 2016 Dec;46(12 ):1459.

PMID:
27305276
24.

Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Oct;25(10):2683. doi: 10.1007/s11136-016-1260-3. No abstract available.

PMID:
27060088
25.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Mar;25(3):625-36. doi: 10.1007/s11136-015-1217-y. Epub 2016 Jan 20. Erratum in: Qual Life Res. 2016 Oct;25(10 ):2683.

26.

Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.

Honeyball F, Murali-Ganesh R, Hruby G, Grimison P.

Intern Med J. 2015 Oct;45(10):1081-4. doi: 10.1111/imj.12881.

PMID:
26429219
27.

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, Covens A, Hurteau J, Stenning SP, Feldman DR, Grimison PS, Huddart RA, Sweeney C, Powles T, Lopes LF, dos Santos Agular S, Chinnaswamy G, Khaleel S, Abouelnaga S, Hale JP, Frazier AL.

J Clin Oncol. 2015 Sep 20;33(27):3018-28. doi: 10.1200/JCO.2014.60.5337. Epub 2015 Aug 24. Review. Erratum in: J Clin Oncol. 2015 Nov 20;33(33):3981.

28.

Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines.

Butow P, Price MA, Shaw JM, Turner J, Clayton JM, Grimison P, Rankin N, Kirsten L.

Psychooncology. 2015 Sep;24(9):987-1001. doi: 10.1002/pon.3920. Epub 2015 Aug 13.

PMID:
26268799
29.

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.

Smith AB, Butow P, Olver I, Luckett T, Grimison P, Toner GC, Stockler MR, Hovey E, Stubbs J, Turner S, Hruby G, Gurney H, Alam M, Cox K, King MT.

J Cancer Surviv. 2016 Apr;10(2):223-33. doi: 10.1007/s11764-015-0468-5. Epub 2015 Jul 16.

PMID:
26178326
30.

Editorial Comment from Dr O'Carrigan and Dr Grimison to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.

O'Carrigan B, Grimison P.

Int J Urol. 2015 Oct;22(10):928-9. doi: 10.1111/iju.12872. Epub 2015 Jul 14. No abstract available.

31.

Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process.

Shaw JM, Price MA, Clayton JM, Grimison P, Shaw T, Rankin N, Butow PN.

Support Care Cancer. 2016 Jan;24(1):33-41. doi: 10.1007/s00520-015-2742-5. Epub 2015 Apr 23.

PMID:
25903929
32.

Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.

Chantrill LA, Nagrial AM, Watson C, Johns AL, Martyn-Smith M, Simpson S, Mead S, Jones MD, Samra JS, Gill AJ, Watson N, Chin VT, Humphris JL, Chou A, Brown B, Morey A, Pajic M, Grimmond SM, Chang DK, Thomas D, Sebastian L, Sjoquist K, Yip S, Pavlakis N, Asghari R, Harvey S, Grimison P, Simes J, Biankin AV; Australian Pancreatic Cancer Genome Initiative (APGI); Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial Management Committee of the Australasian Gastrointestinal Trials Group (AGITG).

Clin Cancer Res. 2015 May 1;21(9):2029-37. doi: 10.1158/1078-0432.CCR-15-0426.

33.

Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer.

Rankin NM, Butow PN, Thein T, Robinson T, Shaw JM, Price MA, Clover K, Shaw T, Grimison P.

BMC Health Serv Res. 2015 Jan 22;15:28. doi: 10.1186/s12913-015-0691-9.

34.

Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.

Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R, Young TA, King MT.

Patient Relat Outcome Meas. 2014 Nov 6;5:119-29. doi: 10.2147/PROM.S68776. eCollection 2014.

35.

Current chemotherapeutic approaches for recurrent or refractory germ cell tumors.

O'Carrigan B, Grimison P.

Urol Oncol. 2015 Aug;33(8):343-54. doi: 10.1016/j.urolonc.2014.09.007. Epub 2014 Oct 11. Review.

PMID:
25308563
36.

The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncology.

Sengupta S, Grimison P, Hayne D, Williams S, Chambers S, DeSouza P, Stockler M, McJannett M, Toner G, Davis ID.

BJU Int. 2015 Jun;115(6):856-8. doi: 10.1111/bju.12925. Epub 2015 Mar 7. No abstract available.

37.

Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.

O'Carrigan B, Fournier M, Olver IN, Stockler MR, Whitford H, Toner GC, Thomson DB, Davis ID, Hanning F, Singhal N, Underhill C, Clingan P, McDonald A, Boland A, Grimison P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

Intern Med J. 2014 Aug;44(8):813-7. doi: 10.1111/imj.12500.

PMID:
25081047
38.

Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.

Grey A, Cooper A, McNeil C, O'Toole S, Thompson J, Grimison P.

Intern Med J. 2014 Jun;44(6):597-600. doi: 10.1111/imj.12415.

PMID:
24946815
39.

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

Grimison PS, Stockler MR, Chatfield M, Thomson DB, Gebski V, Friedlander M, Boland AL, Houghton B, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong SS, Lewis CR, Vasey PA, Toner GC; Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

Ann Oncol. 2014 Jan;25(1):143-8. doi: 10.1093/annonc/mdt369.

PMID:
24356625
40.

Active surveillance is the preferred approach to clinical stage I testicular cancer.

Nichols CR, Roth B, Albers P, Einhorn LH, Foster R, Daneshmand S, Jewett M, Warde P, Sweeney CJ, Beard C, Powles T, Tyldesley S, So A, Porter C, Olgac S, Fizazi K, Hayes-Lattin B, Grimison P, Toner G, Cathomas R, Bokemeyer C, Kollmannsberger C.

J Clin Oncol. 2013 Oct 1;31(28):3490-3. doi: 10.1200/JCO.2012.47.6010. Epub 2013 Sep 3. No abstract available.

PMID:
24002502
41.

The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.

Smith AB, King M, Butow P, Luckett T, Grimison P, Toner GC, Stockler M, Hovey E, Stubbs J, Hruby G, Gurney H, Turner S, Alam M, Cox K, Olver I.

Psychooncology. 2013 Nov;22(11):2557-64. doi: 10.1002/pon.3323. Epub 2013 Jul 3.

PMID:
23825010
42.

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer.

Grimison P, Houghton B, Chatfield M, Toner GC, Davis ID, Martin J, Hovey E, Stockler MR.

BJU Int. 2013 Jul;112(2):E35-43. doi: 10.1111/bju.12221.

43.

Reduced quality of life in internet-panel controls.

Smith A', King M, Butow P, Grimison P, Olver I.

Epidemiology. 2013 May;24(3):462-3. doi: 10.1097/EDE.0b013e31828d4069. No abstract available.

PMID:
23549183
44.

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.

Olver IN, Grimison P, Chatfield M, Stockler MR, Toner GC, Gebski V, Harrup R, Underhill C, Kichenadasse G, Singhal N, Davis ID, Boland A, McDonald A, Thomson D; Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

Support Care Cancer. 2013 Jun;21(6):1561-8. doi: 10.1007/s00520-012-1696-0. Epub 2012 Dec 30.

PMID:
23274926
45.

Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.

Houghton BB, Chalasani V, Hayne D, Grimison P, Brown CS, Patel MI, Davis ID, Stockler MR.

BJU Int. 2013 May;111(6):977-83. doi: 10.1111/j.1464-410X.2012.11390.x. Epub 2012 Dec 17. Review.

46.

Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals.

Grimison P, Phillips F, Butow P, White K, Yip D, Sardelic F, Underhill C, Tse R, Simes R, Turley K, Raymond C, Goldstein D.

Asia Pac J Clin Oncol. 2013 Sep;9(3):226-38. doi: 10.1111/ajco.12014. Epub 2012 Sep 18.

PMID:
22989350
47.

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units.

Fox PN, Chatfield MD, Beith JM, Allison S, Della-Fiorentina S, Fisher D, Turley K, Grimison PS.

ANZ J Surg. 2013 Jul;83(7-8):533-8. doi: 10.1111/j.1445-2197.2012.06254.x. Epub 2012 Sep 18.

PMID:
22984845
48.

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR.

Support Care Cancer. 2013 Feb;21(2):369-76. doi: 10.1007/s00520-012-1526-4. Epub 2012 Jun 21.

PMID:
22717918
49.

The shortage of medical oncologists: the Australian Medical Oncologist Workforce Study.

Blinman PL, Grimison P, Barton MB, Crossing S, Walpole ET, Wong N, Francis K, Koczwara B.

Med J Aust. 2012 Jan 16;196(1):58-61.

PMID:
22256937
50.

Workforce shortages in medical oncology: a looming threat to quality cancer care.

Koczwara B, Barton MB, Walpole ET, Grimison P, Blinman PL, Crossing S, Francis K.

Med J Aust. 2012 Jan 16;196(1):32-3.

PMID:
22256925

Supplemental Content

Loading ...
Support Center